SC Pharmacy Association in support of H.3934
May 5, 2025 Dear Chairman Gagnon, I am writing to express our support for H. 3934, which will have a direct positive impact on the
Chronic and rare disease patients face battles every day that other Americans do not have to deal with. From access to adequate health care, to the cost of treatment and medications to treat their conditions—Policy issues can present opportunities to make meaningful, lasting change for everyone.
May 5, 2025 Dear Chairman Gagnon, I am writing to express our support for H. 3934, which will have a direct positive impact on the
South Carolina gets an F because Ambetter from Absolute Total Care, BlueCross BlueShield of South Carolina, Molina Healthcare, InStil Health, and United Healthcare have copay
People living with serious, complex chronic illness such as HIV and viral hepatitis often rely on high-cost medications to manage their conditions and maintain their
State and National Patient Advocacy Organizations and nonprofits who work and advocate to support chronic and rare patients in South Carolina
Industry, Consultants, Researchers, Hospitals Associations, Universities who support patients access to treatment
Organizations and state agencies who care greatly about patient health care
May 5, 2025 Dear Chairman Gagnon, I am writing to express our support for H. 3934, which will have a direct positive impact on the
H. 3934 General Bill Summary: Pharmacy Benefits. Sponsors: Rep. Kevin Hardee & Rep. Carla Schuessler. Introduced in the House on February 6, 2025.
As of July 2024, South Carolina remains one of 10 states that has yet to expand Medicaid coverage. That leaves almost half a million people
WASHINGTON – Today, Senator Tim Scott’s (R-S.C.) and Senator Cory Booker’s (D-N.J.) Sickle Cell Disease and Other Heritable Blood Disorders Research, Surveillance, Prevention, and Treatment Act of 2023 passed out of the Senate Committee on Health, Education, Labor and Pensions. This legislation reauthorizes the Health Resources and Services Administration’s Sickle Cell Disease Treatment Demonstration Program beyond fiscal year 2023 through fiscal year 2028.
The All Copays Count Coalition comprises more than 80 national 501c3 non-profit, non-partisan patient advocacy and provider organizations representing millions of people living with serious, complex, chronic illness. The people we represent need full and ongoing access to medical care, including specialty medications, to treat their conditions and to keep them healthy.
H. 3309 General Bill Summary: Seizure Safe Schools Act. Sponsors: Reps. Gilliam, Pope, Erickson, Bradley and Davis. Introduced in the House on January 10, 2023.